# Effect of Topical Melatonin Application on Dental Implant Osseointegration and Marginal Bone Level

> **NCT04229719** · PHASE3 · UNKNOWN · sponsor: **University of Baghdad** · enrollment: 10 (estimated)

## Conditions studied

- Alveolar Bone Loss

## Interventions

- **DRUG:** N-acetyl-5-methoxytryptamine

## Key facts

- **NCT ID:** NCT04229719
- **Lead sponsor:** University of Baghdad
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-11-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04229719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04229719, "Effect of Topical Melatonin Application on Dental Implant Osseointegration and Marginal Bone Level". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04229719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*